Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients

Doyle, Adam; Gorgen, Andre; Muaddi, Hala; Aravinthan, Aloysious D.; Issachar, Assaf; Mironov, Oleg; Zhang, Wei; Kachura, John; Beecroft, Robert; Cleary, Sean P.; Ghanekar, Anand; Greig, Paul D.; McGilvray, Ian D; Selzner, Markus; Cattral, Mark S.; Grant, David R.; Lilly, Leslie B.; Selzner, Nazia; Renner, Eberhard L.; Sherman, Morris; Sapisochin, Gonzalo

doi:10.1016/j.jhep.2018.12.027

All Outputs (3)

Donor outcomes in anonymous live liver donation (2019)
Journal Article
Goldaracena, N., Jung, J., Aravinthan, A. D., Abbey, S. E., Krause, S., Pritlove, C., …Grant, D. (2019). Donor outcomes in anonymous live liver donation. Journal of Hepatology, 71(5), 951-959. https://doi.org/10.1016/j.jhep.2019.06.027

Background Death rates on liver transplant waiting lists range from 5%-25%. Herein, we report a unique experience with 50 anonymous persons who volunteered to address this gap by offering to donate part of their liver to a recipient with whom they h... Read More about Donor outcomes in anonymous live liver donation.

The impact of preexisting and post-transplant diabetes mellitus on outcomes following liver transplantation (2019)
Journal Article
Aravinthan, A. D., Fateen, W., Doyle, A. C., Venkatachalapathy, S. V., Issachar, A., Galvin, Z., …Bhat, M. (2019). The impact of preexisting and post-transplant diabetes mellitus on outcomes following liver transplantation. Transplantation, 103(12), 2523-2530. https://doi.org/10.1097/TP.0000000000002757

Background: Diabetes mellitus (DM) is said to adversely affect transplant outcomes. The aim of this study was to investigate the impact of pre-existing and post-transplant DM on liver transplant (LT) recipients. Method: A single centre retrospective... Read More about The impact of preexisting and post-transplant diabetes mellitus on outcomes following liver transplantation.

Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients (2019)
Journal Article
Doyle, A., Gorgen, A., Muaddi, H., Aravinthan, A. D., Issachar, A., Mironov, O., …Sapisochin, G. (2019). Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients. Journal of Hepatology, 70(5), 866-873. https://doi.org/10.1016/j.jhep.2018.12.027

© 2019 European Association for the Study of the Liver Background & Aims: Radiofrequency ablation (RFA) is an effective treatment for single hepatocellular carcinoma (HCC) ≤3 cm. Disease recurrence is common, and in some patients will occur outside t... Read More about Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients.